Arcadia Biosciences, Inc. (RKDA) Operating cash flow 2017–2026
Arcadia Biosciences, Inc. (RKDA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.7MFY2026 · since FY2017: -$17.1M → -$4.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$4.7M | +51.2% |
| FY2025 | -$9.6M | +37.1% |
| FY2024 | -$15.3M | -9.4% |
| FY2023 | -$14.0M | +46.0% |
| FY2022 | -$25.9M | +14.4% |
| FY2021 | -$30.2M | -75.7% |
| FY2020 | -$17.2M | -26.2% |
| FY2019 | -$13.6M | +2.4% |
| FY2018 | -$14.0M | +18.1% |
| FY2017 | -$17.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice